Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
Current Atherosclerosis Reports|November 6, 2017
Novel Approaches for HDL-Directed TherapiesJacques Genest, Hong Y ChoiFrontiers in Pharmacology|June 7, 2021
Identification of Docetaxel as a Potential Drug to Promote HDL BiogenesisHong Y Choi, Isabelle Ruel, Jacques GenestCurrent Opinion in Cardiology|March 22, 2018
HDLs and the pathogenesis of atherosclerosisAdel Schwertani, Hong Y Choi, Jacques GenestCurrent Opinion in Lipidology|November 15, 2017
Membrane microdomains and the regulation of HDL biogenesisJacques Genest, Adel Schwertani, Hong Y ChoiEndocrinology and Metabolism Clinics of North America|August 13, 2022
High-Density Lipoprotein and Cardiovascular Disease-Where do We Stand?Iulia Iatan, Hong Y Choi, Jacques GenestThe Canadian Journal of Cardiology|January 9, 2017
High-Density Lipoproteins: Biology, Epidemiology, and Clinical ManagementHong Y Choi, Anouar Hafiane, Adel Schwertani, et al.Frontiers in Cardiovascular Medicine|January 10, 2022
New Strategies to Promote Macrophage Cholesterol EffluxHong Y Choi, Isabelle Ruel, Shiwon Choi, et al.Biomedicines|February 25, 2023
Biomedical Advances in ABCA1 Transporter: From Bench to BedsideHong Y Choi, Senna Choi, Iulia Iatan, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 2, 2023
Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce AtherosclerosisHong Y Choi, Iulia Iatan, Isabelle Ruel, et al.International Journal of Molecular Sciences|February 26, 2025
Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and AtherosclerosisHong Y Choi, Isabelle Ruel, Shiwon Choi, et al.Pageof 23